Top Markets
Coin of the day
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Clasificación en acciones #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Precio por acción
$0.12164306
Última sincronización: 2024-11-11
Capitalización bursátil
$38.53M
Cambio (1 día)
-4.14%
Cambio (1 año)
0.00%
País
AU
Comercio PharmAust Limited (PAA)

Categoría

Ingresos de PharmAust Limited (PAA)
Ingresos en Jun 2024 TTM: $572.45K
Según los últimos informes financieros de PharmAust Limited, los ingresos actuales de la empresa (TTM) son $572.45K. En 2023, la empresa obtuvo unos ingresos de $1.88M una disminución en comparación con los ingresos del año 2022, que fueron de $2.33M. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de PharmAust Limited desde 2001 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
2026 (TTM) $572.45K 0.00%
2024 0.00 -100.00%
2023 $1.88M -19.32%
2022 $2.33M 45.33%
2021 $1.60M -27.22%
2020 $2.21M -27.76%
2019 $3.05M 26.47%
2018 $2.41M -5.23%
2017 $2.55M 25.80%
2016 $2.02M 10.90%
2015 $1.83M -0.20%
2014 $1.83M 17.05%
2013 $1.56M -5.48%
2012 $1.65M -0.67%
2011 $1.66M 19.79%
2010 $1.39M -2.17%
2009 $1.42M -47.01%
2008 $2.68M -55.73%
2007 $6.05M 33.53%
2006 $4.53M 85.63%
2005 $2.44M 1,047.74%
2004 $212.83K 366.98%
2003 $45.58K -88.07%
2002 $381.98K 0.00%
2001 0.00 0.00%
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
$12.62B 2,205,224.96%
US
$6.02B 1,051,752.00%
NL
$15.70B 2,741,683.32%
AU
$2.23B 389,106.85%
US
- -
CH